OTQualitativeJMIR rehabilitation and assistive technologies2022

A Mixed Reality Cognitive Orthosis to Support Older Adults in Achieving Their Daily Living Activities: Focus Group Study With Clinical Experts.

Amel Yaddaden, Guillaume Spalla, Charles Gouin-Vallerand and 2 others

PMID 35857354

WHAT IT FOUND

Experts identified that older adults with dementia struggle primarily with initiating and planning tasks, not just memory.

They viewed mixed reality headsets as promising for providing visual cues and safety warnings during activities like cooking, though stigma and cost remain barriers.

Key findings

01The main difficulties identified were remembering to complete tasks, initiating tasks, remembering where one is in a task, and planning tasks.

02Experts suggested mixed reality could support three clinical functions: assessment, assistance, and training, with assistance being the most useful.

03Barriers to adoption included social stigma due to the device's appearance, privacy concerns, and the risk of nausea or confusion.

STILL TO COME

How it was doneWhat they foundWhat it means for OTs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study did not include the perspective of older adults with neurodegenerative disorders directly, relying instead on expert proxies. Participants were recruited from a single city, limiting generalizability. The technology described (Microsoft HoloLens 2) was not tested in practice; findings are based on expert opinions about a theoretical application.

Declared interests

The authors declare no conflicts of interest. Funding was provided by the Canadian Institutes of Health Research and other local bodies.

The easy way to misread this

Do not assume mixed reality headsets are proven effective for improving daily living activities in older adults with dementia. This study reports expert opinions on potential uses and barriers, not clinical outcomes from a trial.

Read it on PubMed →